These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11354295)

  • 1. Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins.
    Werdan K
    Ther Apher; 2001 Apr; 5(2):115-22. PubMed ID: 11354295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplemental immune globulins in sepsis.
    Werdan K
    Clin Chem Lab Med; 1999 Mar; 37(3):341-9. PubMed ID: 10353481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pathophysiological and intensive care-resuscitation aspects of septic shock].
    Vasilev D; Karadimov D
    Khirurgiia (Sofiia); 1996; 49(4):9-11. PubMed ID: 8968133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin for treating sepsis and septic shock.
    Alejandria MM; Lansang MA; Dans LF; Mantaring JB
    Cochrane Database Syst Rev; 2001; (2):CD001090. PubMed ID: 11405973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of immunoglobulins in the treatment of patients with sepsis and septic shock.
    Bojić I; Begović V; Trnjak Z; Dokić M
    Vojnosanit Pregl; 1998; 55(2 Suppl):75-8. PubMed ID: 9623363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of intravenous immunoglobulin in the adjuvant treatment of patients with severe sepsis: a Meta analysis].
    Qing Z; Luo Y; Yan S; Zhu H; Huang P; Zhou Z; Shen H; Xie B; He W; Liu X; Li Y; Xu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):407-12. PubMed ID: 29920032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal intravenous immunoglobulin: an important additional strategy in sepsis?
    Di Rosa R; Pietrosanti M; Luzi G; Salemi S; D'Amelio R
    Eur J Intern Med; 2014 Jul; 25(6):511-6. PubMed ID: 24877856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock: a randomised controlled pilot study.
    van der Voort PH; van Zanten M; Bosman RJ; van Stijn I; Wester JP; van Raalte R; Oudemans-van Straaten HM; Zandstra DF
    Eur J Anaesthesiol; 2015 Mar; 32(3):189-98. PubMed ID: 25032942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinically applicable porcine model of septic and ischemia/reperfusion-induced shock and multiple organ injury.
    Kubiak BD; Albert SP; Gatto LA; Vieau CJ; Roy SK; Snyder KP; Maier KG; Nieman GF
    J Surg Res; 2011 Mar; 166(1):e59-69. PubMed ID: 21193206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Biologically Active Adrenomedullin (bio-ADM) Predicts Hemodynamic Support Requirement and Mortality During Sepsis.
    Caironi P; Latini R; Struck J; Hartmann O; Bergmann A; Maggio G; Cavana M; Tognoni G; Pesenti A; Gattinoni L; Masson S;
    Chest; 2017 Aug; 152(2):312-320. PubMed ID: 28411114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early identification and management of patients with severe sepsis and septic shock in the emergency department.
    Keegan J; Wira CR
    Emerg Med Clin North Am; 2014 Nov; 32(4):759-76. PubMed ID: 25441033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View.
    Jarczak D; Kluge S; Nierhaus A
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness.
    Busani S; Damiani E; Cavazzuti I; Donati A; Girardis M
    Minerva Anestesiol; 2016 May; 82(5):559-72. PubMed ID: 26474267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intensive care medicine aspects of infection and septic multiple organ failure].
    Böhrer H; Schmidt H; Bach A
    Zentralbl Chir; 1993; 118(8):482-91. PubMed ID: 8379268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin for treating sepsis and septic shock.
    Alejandria MM; Lansang MA; Dans LF; Mantaring JB
    Cochrane Database Syst Rev; 2000; (2):CD001090. PubMed ID: 10796589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential strategies for inflammatory mediator manipulation: retrospect and prospect.
    Fisher CJ; Zheng Y
    World J Surg; 1996 May; 20(4):447-53. PubMed ID: 8662133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepsis and septic shock.
    Ellrodt AG
    Emerg Med Clin North Am; 1986 Nov; 4(4):809-40. PubMed ID: 3536440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dextran-70 on outcome in severe sepsis; a propensity-score matching study.
    Bentzer P; Broman M; Kander T
    Scand J Trauma Resusc Emerg Med; 2017 Jul; 25(1):65. PubMed ID: 28683810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.